https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — In the recently reported NEPTUNUS-1 and -2 trials, presented at this year’s American College of Rheumatology (ACR) annual meeting, investigators found that the anti-B-cell activating factor receptor (BAFF-R) antibody ianalumab…
:max_bytes(150000):strip_icc()/Health-GettyImages-1649591397-9440b15cbfd54650ac7f5168739cdb28.jpg?w=390&resize=390,220&ssl=1 "You’re Less Likely to Die From a Heart Attack Today, Study Finds")
